Target Metabolite Panels and Lipid Panels for Focused Biomarker Discovery

Trusted and timely insight delivery is of the utmost importance in accelerating drug development. Through its target panels, Sapient can quickly measure metabolites and lipids with known biological significance in a range of diseases, and deliver biomarker data with rapid turnaround to inform next-step decision making.

These focused biomarker discovery analyses – including metabolite panels and lipid panels to assay amino acids, digylcerides, FAHFAs, fatty acids, phospholipids, triglycerides, and VLCDCAs as well as to measure inflammation and metabolic dysregulation – are performed using Sapient’s high throughput, high-sensitivity mass spectrometry method, enabling fast time-to-insight.